These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 8210897)

  • 21. Enhancement of fibrinolysis in poorly controlled, hospitalized type 2 diabetic patients by short-term metabolic control: association with a decrease in plasminogen activator inhibitor 1.
    Aso Y; Okumura KI; Yoshida N; Tayama K; Takemura Y; Inukai T
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):175-80. PubMed ID: 15127320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral hypoglycemic agents in the treatment of type II diabetes.
    Tal A
    Am Fam Physician; 1993 Nov; 48(6):1089-95. PubMed ID: 8237731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treating postprandial hyperglycemia does not appear to delay progression of early type 2 diabetes: the Early Diabetes Intervention Program.
    Kirkman MS; Shankar RR; Shankar S; Shen C; Brizendine E; Baron A; McGill J
    Diabetes Care; 2006 Sep; 29(9):2095-101. PubMed ID: 16936159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Rational therapy of Type II diabetes].
    Hanefeld M; Fischer S
    Ther Umsch; 1996 Dec; 53(12):914-24. PubMed ID: 9036569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Physiopathological premises in the treatment of insulin-independent diabetics].
    Rossi G
    Recenti Prog Med; 1981 Mar; 70(3):285-91. PubMed ID: 7017850
    [No Abstract]   [Full Text] [Related]  

  • 26. Office clues to diabetes problems.
    Danowski TS
    Geriatrics; 1982 Jun; 37(6):61-3, 67-8, 71, 75-6. PubMed ID: 6804307
    [No Abstract]   [Full Text] [Related]  

  • 27. Combined insulin and oral sulfonylureas--how sweet it isn't!
    Ponte CD
    DICP; 1990 Dec; 24(12):1234-5. PubMed ID: 2089839
    [No Abstract]   [Full Text] [Related]  

  • 28. Comment on Jakubowicz et al. Fasting Until Noon Triggers Increased Postprandial Hyperglycemia and Impaired Insulin Response After Lunch and Dinner in Individuals With Type 2 Diabetes: A Randomized Clinical Trial. Diabetes Care 2015;38:1820-1826.
    Ganda OP
    Diabetes Care; 2016 Feb; 39(2):e28. PubMed ID: 26798157
    [No Abstract]   [Full Text] [Related]  

  • 29. [Provisional intensive insulin therapy in non-insulin-dependent diabetes resistant to usual treatment].
    Bringer J; Galtier-Dereure F; Augustin-Pascalis I; Richard JL; Parer-Richard C; Mirouze J; Jaffiol C
    Journ Annu Diabetol Hotel Dieu; 1993; ():115-22. PubMed ID: 8331859
    [No Abstract]   [Full Text] [Related]  

  • 30. Diabetes: Breakfast most important meal of the day, especially for patients with T2DM.
    Geach T
    Nat Rev Endocrinol; 2015 Oct; 11(10):566. PubMed ID: 26284449
    [No Abstract]   [Full Text] [Related]  

  • 31. Gluconeogenesis in type 2 diabetes.
    Gerich JE; Nurjhan N
    Adv Exp Med Biol; 1993; 334():253-8. PubMed ID: 8249688
    [No Abstract]   [Full Text] [Related]  

  • 32. Selective versus total insulin resistance: a pathogenic paradox.
    Brown MS; Goldstein JL
    Cell Metab; 2008 Feb; 7(2):95-6. PubMed ID: 18249166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin resistance underlying type 2 diabetes.
    Lima LMTR
    Lancet Diabetes Endocrinol; 2019 Jun; 7(6):424. PubMed ID: 31103174
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of sulphonylurea therapy on in vivo insulin sensitivity in non-insulin dependent diabetics.
    Ponchner M; Taylor R; Heine R; Alberti KG
    Horm Metab Res; 1984 Apr; 16(4):208. PubMed ID: 6373546
    [No Abstract]   [Full Text] [Related]  

  • 35. Hyperglycaemic siblings of Type II (non-insulin-dependent) diabetic patients have increased PAI-1, central obesity and insulin resistance compared with their paired normoglycaemic sibling.
    Herlihy OM; Barrow BA; Grant PJ; Levy JC
    Diabetologia; 2002 May; 45(5):635-41. PubMed ID: 12107743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metformin: a new treatment option for non-insulin-dependent diabetes mellitus.
    Goo AK; Carson DS; Bjelajac A
    J Fam Pract; 1996 Jun; 42(6):612-8. PubMed ID: 8656173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Factors responsible for fasting hyperglycemia in the non-insulin-dependent diabetic patient].
    Tappy L
    Rev Med Suisse Romande; 1993 Sep; 113(9):699-701. PubMed ID: 8210897
    [No Abstract]   [Full Text] [Related]  

  • 38. Are oral hypoglycemic agents likely to benefit NIDDM patients? Affirmative.
    Lebovitz HE
    Hosp Pract (Off Ed); 1992 Feb; 27 Suppl 1():26-31; discussion 35-6. PubMed ID: 1347536
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.